For: | Ding L, Chen XP, Zhang ZW, Guan J, Zhang WG, Wang HP, Wang ZH, Li CL. Synergistic effect of bromocriptine and tumor necrosis factor-α on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm. World J Gastroenterol 2005; 11(36): 5621-5626 [PMID: 16237754 DOI: 10.3748/wjg.v11.i36.5621] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i36/5621.htm |
Number | Citing Articles |
1 |
Zhaohui Qiu, Jie Peng, Lingli Mou, Xiao Li, Fanqi Meng, Peng Yu. Development and application of a UPLC–MS/MS method for P-glycoprotein quantification in human tumor cells. Journal of Chromatography B 2018; 1084: 14 doi: 10.1016/j.jchromb.2018.03.007
|
2 |
WOLFGANG WALTHER, DENNIS KOBELT, LISA BAUER, JUTTA AUMANN, ULRIKE STEIN. Chemosensitization by diverging modulation by short-term and long-term TNF-α action on ABCB1 expression and NF-κB signaling in colon cancer. International Journal of Oncology 2015; 47(6): 2276 doi: 10.3892/ijo.2015.3189
|
3 |
Morteza Ghandadi, Javad Behravan, Khalil Abnous, Melika Ehtesham Gharaee, Fatemeh Mosaffa. TNF-α exerts cytotoxic effects on multidrug resistant breast cancer MCF-7/MX cells via a non-apoptotic death pathway. Cytokine 2017; 97: 167 doi: 10.1016/j.cyto.2017.06.014
|
4 |
Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli. Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. World Journal of Hepatology 2010; 2(3): 114-126 doi: 10.4254/wjh.v2.i3.114
|
5 |
Faiza Naz, Abdul Malik, Muhammad Riaz, Qaisar Mahmood, Malik Hassan Mehmood, Ghulam Rasool, Zahed Mahmood, Mazhar Abbas. Bromocriptine therapy: Review of mechanism of action, safety and tolerability. Clinical and Experimental Pharmacology and Physiology 2022; 49(8): 903 doi: 10.1111/1440-1681.13678
|
6 |
Marina Ricci, Marta Miola, Cristina Multari, Ester Borroni, Rosa Angela Canuto, Noemi Congiusta, Enrica Vernè, Antonia Follenzi, Giuliana Muzio. PPARs are mediators of anti-cancer properties of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with conjugated linoleic acid. Chemico-Biological Interactions 2018; 292: 9 doi: 10.1016/j.cbi.2018.07.003
|
7 |
Giuliana Muzio, Giuseppina Barrera, Stefania Pizzimenti. Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer. Antioxidants 2021; 10(11): 1734 doi: 10.3390/antiox10111734
|
8 |
Lijuan Bai, Xin Li, Yang Yang, Rui Zhao, Elshaddai Z. White, Alira Danaher, Nathan J. Bowen, Cimona V. Hinton, Nicholas Cook, Dehong Li, Alyssa Y. Wu, Min Qui, Yuhong Du, Haian Fu, Omer Kucuk, Daqing Wu. Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models. Translational Oncology 2023; 34: 101707 doi: 10.1016/j.tranon.2023.101707
|
9 |
Soo Hyung Ryu, Young-Hwa Chung. How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinoma. Liver International 2010; 30(4): 496 doi: 10.1111/j.1478-3231.2010.02215.x
|
10 |
Yu Peng Wu, Yi Bao Wang, Zhe Bao Wu. Bromocriptine-responsive supersellar germinoma with the expression of dopamine receptors: A case report. Clinical Neurology and Neurosurgery 2019; 176: 15 doi: 10.1016/j.clineuro.2018.11.006
|
11 |
Detlef Bartkowiak, Michael Stempfhuber, Thomas Wiegel, Dirk Bottke. Radiation- and Chemoinduced Multidrug Resistance in Colon Carcinoma Cells. Strahlentherapie und Onkologie 2009; 185(12): 815 doi: 10.1007/s00066-009-1993-9
|
12 |
Hyun-Ju Kim, Jae-Young Um, Yun-Kyung Kim. Association of a multidrug resistance 1 gene polymorphism and colorectal cancer in the Korean population. Oriental Pharmacy and Experimental Medicine 2013; 13(3): 225 doi: 10.1007/s13596-013-0136-0
|